Top Markets
Coin of the day
Regent Pacific Group Limited Regent Pacific Group Limited

Regent Pacific Group Limited

0575
Rangering i aksjer #27223
Endurance RP Limited functions as an investment holding company, concentrating... Endurance RP Limited functions as an investment holding company, concentrating its investments within the healthcare and life sciences sectors across the People's Republic of China, Europe, Hong Kong, and Taiwan. The firm organizes its activities into two primary divisions: Biopharma and Corporate Investment. The Biopharma segment is responsible for the research, development, production, promotion, and distribution of pharmaceutical products aimed at addressing and managing urological disorders. This division also innovates artificial intelligence systems to precisely track the pace of aging, examining it at molecular, cellular, tissue, organ, systemic, physiological, and psychological levels. Through its Corporate Investment division, the company strategically invests in both publicly traded and privately held corporate entities. Additionally, it extends its services to include management consulting and corporate financial advice. Incorporated in 1991 and headquartered in Central, Hong Kong, Endurance RP Limited adopted its current name in June 2021, having previously operated as Regent Pacific Group Limited.
Aksjekurs
$0.11769213
Sist synkronisert: 2026-07-30
Markedsverdi
$34.34M
Endring (1 dag)
0.00%
Endring (1 år)
9.45%
Land
HK
Handel Regent Pacific Group Limited (0575)

Kategori

Inntekter for Regent Pacific Group Limited (0575)
Inntekter i 2026 TTM: 0
Ifølge Regent Pacific Group Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Regent Pacific Group Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$9.17B -
US
$8.07B -
US
- -
SE
$6.24B -
US
$3.70B -
US